BioLife Corporate Profile

BioLife Corporate Profile

Financials

2021 Annual Revenue
$30.17 Billion

2021 Gross Profit
$20.79 Billion

2021 Annual Net Income
$3.55 Billion

2021 Number of Stores
180

2021 Gross cProfit Growth
2.67%

Credit Rating

Leases guaranteed by Baxalta, Inc., which senior unsecured notes are Investment Grade BBB+

BioLife Corporate Profile

BioLife Corporate Profile

BioLife Plasma Services is a leading company for high-quality plasma collection. A part of a global biopharmaceutical company, Takeda Pharmaceutical Compnay Limited (NYSE:TAK), BioLife continues to use high-quality plasma for the benefit of those in need. The financials and credit ratings presented are representative of the consolidated results of Takeda Pharmaceutical Company, which is BioLife Plasma Services’s parent entity.

ExchangeRight

1055 E. Colorado Blvd, Suite 310
Pasadena, CA 91106

Phone: (855) 317-4448
Fax: (877) 711-4047
Email: info@exchangeright.com

Subscribe

Receive our investment announcements and equity updates.